Correlation Between Citius Oncology, and Evoke Pharma
Can any of the company-specific risk be diversified away by investing in both Citius Oncology, and Evoke Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citius Oncology, and Evoke Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citius Oncology, and Evoke Pharma, you can compare the effects of market volatilities on Citius Oncology, and Evoke Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citius Oncology, with a short position of Evoke Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citius Oncology, and Evoke Pharma.
Diversification Opportunities for Citius Oncology, and Evoke Pharma
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Citius and Evoke is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Citius Oncology, and Evoke Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evoke Pharma and Citius Oncology, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citius Oncology, are associated (or correlated) with Evoke Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evoke Pharma has no effect on the direction of Citius Oncology, i.e., Citius Oncology, and Evoke Pharma go up and down completely randomly.
Pair Corralation between Citius Oncology, and Evoke Pharma
Given the investment horizon of 90 days Citius Oncology, is expected to under-perform the Evoke Pharma. In addition to that, Citius Oncology, is 2.37 times more volatile than Evoke Pharma. It trades about -0.15 of its total potential returns per unit of risk. Evoke Pharma is currently generating about -0.05 per unit of volatility. If you would invest 2,040 in Evoke Pharma on September 12, 2024 and sell it today you would lose (1,632) from holding Evoke Pharma or give up 80.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 24.15% |
| Values | Daily Returns |
Citius Oncology, vs. Evoke Pharma
Performance |
| Timeline |
| Citius Oncology, |
| Evoke Pharma |
Citius Oncology, and Evoke Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Citius Oncology, and Evoke Pharma
The main advantage of trading using opposite Citius Oncology, and Evoke Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citius Oncology, position performs unexpectedly, Evoke Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evoke Pharma will offset losses from the drop in Evoke Pharma's long position.| Citius Oncology, vs. Evoke Pharma | Citius Oncology, vs. Dynavax Technologies | Citius Oncology, vs. Amphastar P | Citius Oncology, vs. Lantheus Holdings |
| Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |